CIAM
CATX icon

Caitong International Asset Management’s Perspective Therapeutics CATX Stock Holding History

Caitong International Asset Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.57K Buy
1,340
+1,001
+295% +$3.78K ﹤0.01% 1301
2026
Q1 		$1.41K Sell
339
-30,288
-99% -$128K ﹤0.01% 1322
2025
Q4 		$84.2K Buy
+30,627
New +$87.4K 0.02% 501
2025
Q2 		– Sell
-895
Closed -$1.91K – 2044
2025
Q1 		$1.91K Buy
895
+780
+678% +$2.34K ﹤0.01% 1368
2024
Q4 		$367 Buy
+115
New +$939 ﹤0.01% 1504

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Caitong International Asset Management's CATX Position: Q2 2026 in Review

Caitong International Asset Management increased its Perspective Therapeutics (CATX) stake by 295% in Q2 2026, buying an estimated $3.78K and bringing the position to 1,340 shares worth $4.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.

Caitong International Asset Management first reported a position in CATX in Q4 2024 and has held it in 5 quarters since. The position peaked at $84.2K in Q4 2025. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Caitong International Asset Management held 1,340 shares of Perspective Therapeutics worth $4.57K as of Q2 2026.
  • Caitong International Asset Management bought 1,001 Perspective Therapeutics shares in Q2 2026, an estimated $3.78K.
  • Perspective Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1301 holding.
  • Caitong International Asset Management first reported a position in Perspective Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Perspective Therapeutics position peaked at $84.2K in Q4 2025.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.